Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

COPLEY NEW VP-SCIENTIFIC AFFAIRS IS FORMER FDAer SKELLY

This article was originally published in The Tan Sheet

Executive Summary

COPLEY NEW VP-SCIENTIFIC AFFAIRS IS FORMER FDAer SKELLY, who will "direct the company's regulatory affairs, research and product development programs," the Canton, Mass.-based generic drug company announced Nov. 9. Jerome Skelly, PhD, spent 20 years with FDA, most recently as deputy director for the Center for Drug Evaluation & Research's Office of Research Resources, where, Copley said, he was responsible for "developing and improving systems and procedures for verifying data submitted to FDA," Copley said.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083423

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel